Jacobio Pharmaceuticals Group Co., Ltd. (OTCMKTS:JBPHF – Get Free Report) was the target of a large growth in short interest in May. As of May 29th, there was short interest totaling 900 shares, a growth of ? from the May 14th total of 0 shares. Based on an average daily volume of 0 shares, the days-to-cover ratio is currently ? days.
Jacobio Pharmaceuticals Group Price Performance
JBPHF stock opened at $0.87 on Friday. The firm’s 50 day moving average price is $0.87 and its 200-day moving average price is $0.86. Jacobio Pharmaceuticals Group has a one year low of $0.73 and a one year high of $1.10.
Jacobio Pharmaceuticals Group Company Profile
Jacobio Pharmaceuticals Group Co, Ltd. is a clinical?stage biopharmaceutical company headquartered in Tianjin, China, specializing in the discovery and development of small?molecule therapeutics for oncology. The company’s research platform is built around targeted kinase inhibitors and epigenetic modulators aimed at addressing acute leukemias and select solid tumors with high unmet medical need.
Jacobio’s pipeline comprises multiple preclinical and clinical?stage programs focused on genetically defined cancers, including agents designed to inhibit mutant FLT3, menin?MLL interactions and other oncogenic drivers.
Read More
- Five stocks we like better than Jacobio Pharmaceuticals Group
- Time to Sell? 3 Winners With Fading Technical Momentum
- Why These 2 Hotel Stocks Are Beating Travel Peers
- This Energy Stock Has Quietly Soared 130% in a Year
- 3 ‘Boring’ Dividend Stocks With Tasty Technical Setups
Receive News & Ratings for Jacobio Pharmaceuticals Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Jacobio Pharmaceuticals Group and related companies with MarketBeat.com's FREE daily email newsletter.
